95 related articles for article (PubMed ID: 8251725)
1. [Effect of qigong on plasma coagulation fibrinolysis indices of hypertensive patients with blood stasis].
Wang CX; Xu DH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Jul; 13(7):415-6, 389. PubMed ID: 8251725
[TBL] [Abstract][Full Text] [Related]
2. [Effect of qigong on heart-qi deficiency and blood stasis type of hypertension and its mechanism].
Wang CX; Xu DH; Qian YC
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Aug; 15(8):454-8. PubMed ID: 8580689
[TBL] [Abstract][Full Text] [Related]
3. [The kinetics of plasma coagulation fibrinolysis levels in acute myocardial infarction before and after treatment with intravenous urokinase].
Bai XJ; Chen CX; He YL
Zhonghua Nei Ke Za Zhi; 1991 Apr; 30(4):205-7, 253. PubMed ID: 1908371
[TBL] [Abstract][Full Text] [Related]
4. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
5. Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease.
Ozoran K; Dügün N; Gürler A; Tutkak H; Tokgöz G
Scand J Rheumatol; 1995; 24(6):376-82. PubMed ID: 8610223
[TBL] [Abstract][Full Text] [Related]
6. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
7. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
8. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study on active factors of vascular endothelial cells in acute cerebral infarction patients and therapeutical effect of activating blood stasis].
Lin S; Lian Q; Liang H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Jul; 18(7):392-5. PubMed ID: 11477811
[TBL] [Abstract][Full Text] [Related]
10. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator.
Schved JF; Gris JC; Arnaud A; Martinez P; Sanchez N; Wautier JL; Sarlat C
J Lab Clin Med; 1992 Sep; 120(3):411-9. PubMed ID: 1517688
[TBL] [Abstract][Full Text] [Related]
11. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
[TBL] [Abstract][Full Text] [Related]
12. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
14. [The indices of the fibrinolysis, blood coagulation and lipid transport systems in hypertension patients].
Sorokin EV; Karpov IuA; Dobrovol'skiĭ AB; Vil'chinskaia MIu; Panchenko EP; Titaeva EV; Kagan-Ponomarev MIa
Ter Arkh; 1996; 68(9):19-23. PubMed ID: 9005605
[TBL] [Abstract][Full Text] [Related]
15. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
[TBL] [Abstract][Full Text] [Related]
16. Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement.
Flordal PA; Ljungström KG; Svensson J; Ekman B; Neander G
Thromb Haemost; 1991 Dec; 66(6):652-6. PubMed ID: 1796409
[TBL] [Abstract][Full Text] [Related]
17. Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus.
Ruiz-Argüelles GJ; Ruiz-Argüelles A; Lobato-Mendizábal E; Díaz-Gomez F; Pacheco-Pantoja E; Drenkard C; Alarcón-Segovia D
Am J Hematol; 1991 May; 37(1):9-13. PubMed ID: 1902623
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell haemostatic function after heart transplantation.
Hunt BJ; Segal H; Yacoub M
Transplant Proc; 1991 Feb; 23(1 Pt 2):1182-3. PubMed ID: 1899155
[No Abstract] [Full Text] [Related]
20. Plasma coagulation profiles in patients with severe primary pulmonary hypertension.
Hoeper MM; Sosada M; Fabel H
Eur Respir J; 1998 Dec; 12(6):1446-9. PubMed ID: 9877507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
